Egyptian International Pharmaceutical Industries Company (PHAR) - Financial and Strategic Analysis Review --- Aarkstore Enterprise

HTML clipboardin pdf format within two business days (excluding
Egyptian International Pharmaceutical Industriesweekends).
Company (PHAR) - Financial and Strategic AnalysisThe profile contains critical company information
Reviewincluding*,
Egyptian International Pharmaceutical Industries- Business description – A detailed description of
Company (EIPIC) is a pharmaceutical company,the company's operations and business divisions.
engaged in the production, sale and export of- Corporate strategy – Analyst's summarization
pharmaceutical products. The company specializes inof the company's business strategy.
veterinary and generic chemical medicine, cosmetics,- SWOT Analysis – A detailed analysis of the
special foods and pesticides. Its product portfoliocompany's strengths, weakness, opportunities and
includes anesthetics, analgesics, antidotes, vitaminsthreats.
and minerals, endocrine system drugs, antacids, ulcer- Company history – Progression of key events
healing drugs, soft gelatin capsules, lyophilizedassociated with the company.
products, gels, sprayers, and tablets. In addition,- Major products and services – A list of major
EIPIC develops interferon, colony stimulating factor,products, services and brands of the company.
human growth hormone, and interleukin. The- Key competitors – A list of key competitors to
company certified with ISO 9001 and ISO 14001.the company.
This comprehensive SWOT profile of Egyptian- Key employees – A list of the key executives
International Pharmaceutical Industries Companyof the company.
provides you an in-depth strategic analysis of the- Executive biographies – A brief summary of the
company's businesses and operations. The profile hasexecutives' employment history.
been compiled to bring to you a clear and an- Key operational heads – A list of personnel
unbiased view of the company's key strengths andheading key departments/functions.
weaknesses and the potential opportunities and- Important locations and subsidiaries – A list and
threats. The profile helps you formulate strategiescontact details of key locations and subsidiaries of
that augment your business by enabling you tothe company.
understand your partners, customers and- Key manufacturing facilities – A list of key
competitors better.manufacturing facilities of the company.
This company report forms part of the ‘Profile- Detailed financial ratios for the past five years –
on Demand' service, covering over 50,000 of theThe latest financial ratios derived from the annual
world's leading companies. Once purchased, the highlyfinancial statements published by the company with 5
qualified team of company analysts willyears history.
comprehensively research and author a full financial- Interim ratios for the last five interim periods –
and strategic analysis of Egyptian InternationalThe latest financial ratios derived from the quarterly
Pharmaceutical Industries Company, including asemi-annual financial statements published by the
detailed SWOT analysis, and deliver this direct to youcompany for 5 interims history.